Gene · 51816
Papers4,003
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 4,003
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Extracellular matrix mediates circulating tumor cell clustering in triple-negative breast cancer metastasis. | Nat Commun | 2026 | 41651843 | PubTator, text mining | PubMed |
| CDK2 inhibition promotes neuronal differentiation in neuroblastoma. | Sci Rep | 2026 | 41644599 | PubTator, text mining | PubMed |
| Cytoplasmic poly-adenosine binding proteins modulate susceptibility of mRNAs to Pumilio-mediated decay. | Nucleic Acids Res | 2026 | 41641701 | PubTator, text mining | PubMed |
| Metabolic characterization of tumor-immune interactions by multiplexed immunofluorescence reveals spatial mechanisms of immunotherapy response in non-small cell lung carcinoma (NSCLC). | Nat Commun | 2026 | 41634004 | PubTator, text mining | PubMed |
| Myo1f regulates monocyte adhesion and contributes to atherosclerosis via MRTFA-dependent ITGB2 expression. | Redox Biol | 2026 | 41610517 | PubTator, text mining | PubMed |
| Paraneoplastic cerebellar degeneration from an isolated nodal clear cell carcinoma of suspected gynecologic origin: case report and literature review. | J Cancer Res Clin Oncol | 2026 | 41593408 | PubTator, text mining | PubMed |
| Reciprocal regulation of hMENA and TGF-β signaling in cancer-associated fibroblasts promotes EMT, immunosuppression, poor prognosis, and ICT resistance in NSCLC. | J Immunother Cancer | 2026 | 41592891 | PubTator, text mining | PubMed |
| Tumor-associated macrophages in head and neck carcinoma: clinicopathological correlations and implications for immunotherapy. | Cancer Immunol Immunother | 2026 | 41591510 | PubTator, text mining | PubMed |
| Decoding RNA triple helices: identification from sequence and secondary structure. | Brief Bioinform | 2026 | 41587321 | PubTator, text mining | PubMed |
| Emergence of the novel PA-D27G mutation conferring reduced baloxavir susceptibility in influenza A viruses circulating in China, 2018-2025. | Emerg Microbes Infect | 2026 | 41555529 | PubTator, text mining | PubMed |
| Characterizing the molecular and clinical implications of NRG1 fusions in NSCLC through integrated RNA and DNA sequencing analysis. | Eur J Med Res | 2026 | 41555462 | PubTator, text mining | PubMed |
| Expanding the toolbox to develop IAP-based degraders of TEAD transcription factors. | Commun Chem | 2026 | 41554911 | PubTator, text mining | PubMed |
| Clinicopathologic and molecular spectrum of gastrointestinal stromal tumor (GIST) with NTRK fusion and marked response to larotrectinib in GIST with NTRK fusion: a case report. | Cell Oncol (Dordr) | 2026 | 41553644 | PubTator, text mining | PubMed |
| The AHCY-adenosine complex rewires mRNA methylation to enhance fatty acid biosynthesis and tumorigenesis. | Cell Res | 2026 | 41549122 | PubTator, text mining | PubMed |
| West Nile virus: epidemiology, prevention, clinical features, diagnosis, treatment, and open research questions. | Ann Med | 2026 | 41546488 | PubTator, text mining | PubMed |
| Lactate derived from cancer-associated fibroblasts promotes alternative splicing and castration resistance in prostate cancer. | Sci Adv | 2026 | 41544173 | PubTator, text mining | PubMed |
| Molecular, Transcriptomic, and Proteomic Characterization of Plasmodium Infections that Evade Detection by Rapid Diagnostic Tests in Mizan Aman, Ethiopia. | medRxiv | 2026 | 41542666 | PubTator, text mining | PubMed |
| Advances on drug therapy for KRASG12C-mutant non-small-cell lung cancer. | Transl Oncol | 2026 | 41529383 | PubTator, text mining | PubMed |
| Clinical Characteristics and Spatial Transcriptome Analysis of Non-Small Cell Lung Cancers Exhibiting Early Alectinib Resistance: A Retrospective OLCSG Study. | Cancer Res Commun | 2026 | 41529251 | PubTator, text mining | PubMed |
| CD40L and IL-4 lymph node-associated signals protect B cells from rituximab-induced ADCC via KIR and NKG2A. | Clin Exp Immunol | 2026 | 41528734 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51816/papers?page=6